Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Cellular and Molecular Medicine|December 19, 2024
Targeting the GDF15 Signalling for Obesity Treatment: Recent Advances and Emerging ChallengesJincheng Zhang, Jingquan Sun, Jielang Li, et al.
Frontiers in Immunology|June 27, 2024
Effectiveness of PD-1 inhibitor-based first-line therapy in Chinese patients with metastatic gastric cancer: a retrospective real-world studyYichun Duan, Jielang Li, Shuang Zhou, et al.
Tumori|July 23, 2021
Efficacy of lenvatinib plus pembrolizumab in hepatocellular carcinoma with metachronous lung metastasis: a report of two casesJieLang Li, Ting Chen, Feng Bi, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 11, 2023
Capecitabine/cisplatin combined with concurrent intensity-modulated radiation therapy: a feasible therapeutic strategy for anal squamous cell carcinomaJielang Li, Chen Huang, Xin Wang, et al.
Frontiers in Immunology|September 11, 2023
Favorable response to PD-1 inhibitor plus chemotherapy as first-line treatment for metastatic follicular dendritic cell sarcoma of the spleen: a case reportJielang Li, Min Ren, Feng Bi, et al.
Scandinavian Journal of Gastroenterology|February 8, 2021
Cisplatin/capecitabine with intensity-modulated radiation therapy in anal squamous cell carcinoma: a preliminary studyJielang Li, Huanji Xu, Jiahuan Zou, et al.
Cancer Science|May 2, 2021
Casp8 acts through A20 to inhibit PD-L1 expression: The mechanism and its implication in immunotherapyJiahuan Zou, Hongwei Xia, Chenliang Zhang, et al.
IEEE Journal of Biomedical and Health Informatics|November 1, 2023
A SwinTransformer-Based Segmentation Framework With Self-Supervised Strategy for Post-Operative Prostate Cancer RadiotherapyDong Miao, Jielang Li, Meng Dou, et al.
Innate Immunity|October 5, 2012
TLR3 activation efficiency by high or low molecular mass poly I:CYu Zhou, Ming Guo, Xu Wang, et al.
Cell Reports|May 6, 2026
Accumulated sotorasib-bound KRASG12C reactivates the MAPK pathway and drives sotorasib resistance via the DHX9-RAC1-PAK1 axisGongmin Zhu, Lijiao Pei, Jue Li, et al.
Pageof 1